Abstract:The continuous threats posed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, including the emergence of potentially more infectious and deadly variants, necessitate ongoing studies to uncover novel and detailed mechanisms driving disease severity. Using single-cell transcriptomics, we conducted a secondary data analysis of bronchoalveolar lavage fluid (BALF) from COVID-19 patients of varying severities and healthy controls to comprehensively examine immune responses. We observed significant immune cell alterations correlating with disease severity. In severe cases, macrophages showed upregulation of pro-inflammatory genes TNFα and IL1β, contributing to severe inflammation and tissue damage. Neutrophils exhibited increased activation, marked by S100A8, CXCL8, and IL1β expression, with extended viability and reduced phagocytosis. Genes such as MCL1 and HIF1α supported extended viability, while MSR1 and MRC1 indicated reduced phagocytosis. Enhanced formation of neutrophil extracellular traps (NETs) and reduced clearance, indicated by NET-associated markers, were linked to thrombo-inflammation and organ damage. Both macrophages and neutrophils in severe cases showed impaired efferocytosis, indicated by decreased expression of MSR1 and TREM2 in macrophages and downregulation of FCGR3B in neutrophils, leading to the accumulation of apoptotic cells and exacerbating inflammation. Severe cases were characterized by M1 macrophages with high TNFα and IL1β, while milder cases had M2 macrophages with elevated PPARγ. Low-density neutrophils (LDNs) increased significantly in severe cases, showing higher CXCR4 and CD274 and lower FCGR3B compared to high-density neutrophils (HDNs). NK and T cells in severe cases demonstrated altered receptor and gene expression, with increased activation markers IFNγ and ISG15, suggesting a paradoxical state of activation and exhaustion. This imbalance suggests a potential mechanism for immune dysregulation and ineffective antiviral responses in severe COVID-19. This analysis highlights the critical role of dysregulated neutrophil, macrophage, NK, and T cell responses in severe COVID-19, identifying potential therapeutic targets and providing novel insights into the disease.

High generation of reactive oxygen species from neutrophils in patients with severe COVID-19

Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19

Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls

The Impact of Serum Levels of Reactive Oxygen and Nitrogen Species on the Disease Severity of COVID-19

Pathogenic neutrophilia drives acute respiratory distress syndrome in severe COVID-19 patients

Extensive acute and sustained changes to neutrophil proteomes post-SARS-CoV-2 infection

Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections

Systemic redox imbalance in severe COVID‐19 patients

A neutrophil activation signature predicts critical illness and mortality in COVID-19

New insights into extracellular and intracellular redox status in COVID-19 patients

The Potential Role of Reactive Oxygen Species Produced by Low-Density Neutrophils in Periodontitis

Neutrophil NADPH oxidase breaks the inflammatory IL-1beta/IL-17A circuit to enhance pathogen clearance during respiratory virus infections.

Hypoxia and Activation of Neutrophil Degranulation-Related Genes in the Peripheral Blood of COVID-19 Patients

Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19

Inflammasome activation in neutrophils of patients with severe COVID-19

Neutrophils in COVID-19: Recent Insights and Advances

Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies

ScRNA-Seq study of neutrophils reveals vast heterogeneity and breadth of inflammatory responses in severe COVID-19 patients

Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19

Immune Characteristic Genes and Neutrophil Immune Transformation Studies in Severe COVID-19

Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in Patients